Literature DB >> 2447273

Substance P and vasoactive intestinal peptide degradation by mast cell tryptase and chymase.

G H Caughey1, F Leidig, N F Viro, J A Nadel.   

Abstract

The peptides substance P (SP) and vasoactive intestinal peptide (VIP) released from peptidergic neurons have potent effects on gland secretion and on smooth muscle tone. Because mast cells release proteases during degranulation, and are located in many of the same tissue microenvironments into which SP and VIP are released, we wished to examine whether mast cell proteases, by cleaving and thus inactivating these peptides, could modulate their effects. We used active site-titrated preparations of the two major neutral proteases of mast cell granules, tryptase and chymase, to determine the sites and rates of cleavage of SP and VIP. The proteases were purified from dog mastocytomas. Tryptase cleaved VIP rapidly at two sites with a kcat/Km of 2.2 X 10(5) sec-1 M-1, but had no effect on SP. Chymase cleaved both SP and VIP at primarily a single site with kcat/Km of 3.9 X 10(4) and 5.4 X 10(4) sec-1 M-1, respectively. Thus, these data show that mast cell proteases degrade SP and VIP. The differences in peptidase activity between tryptase and chymase suggest that the consequences of protease release could vary according to mast cell protease phenotype and location in various tissues and species. Tryptase, by cleaving the bronchodilator VIP but not the bronchoconstrictor SP, might promote bronchial hyper-responsiveness in asthma by decreasing the nonadrenergic neural inhibitory influence mediated by VIP. In skin and other tissues, chymase might interrupt axon reflex-mediated neurogenic inflammation by cleaving SP.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2447273

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  60 in total

Review 1.  The diverse effects of mast cell mediators.

Authors:  Colleen Hines
Journal:  Clin Rev Allergy Immunol       Date:  2002-04       Impact factor: 8.667

Review 2.  Roles of mast cell proteases in airways.

Authors:  J A Nadel
Journal:  Drugs       Date:  1989       Impact factor: 9.546

Review 3.  Role of Tissue Renin-angiotensin System and the Chymase/angiotensin-( 1-12) Axis in the Pathogenesis of Diabetic Retinopathy.

Authors:  Mohammad Shamsul Ola; Abdullah S Alhomida; Carlos M Ferrario; Sarfaraz Ahmad
Journal:  Curr Med Chem       Date:  2017       Impact factor: 4.530

Review 4.  Mast cell peptidases: chameleons of innate immunity and host defense.

Authors:  Neil N Trivedi; George H Caughey
Journal:  Am J Respir Cell Mol Biol       Date:  2009-11-20       Impact factor: 6.914

Review 5.  Mast cell plasticity and sphingosine-1-phosphate in immunity, inflammation and cancer.

Authors:  Carole A Oskeritzian
Journal:  Mol Immunol       Date:  2014-04-22       Impact factor: 4.407

6.  Quantitative analysis of contact sites between mast cells and sensory nerves in cutaneous psoriasis and lichen planus based on a histochemical double staining technique.

Authors:  A Naukkarinen; I T Harvima; M L Aalto; R J Harvima; M Horsmanheimo
Journal:  Arch Dermatol Res       Date:  1991       Impact factor: 3.017

7.  Effects of epithelium removal on relaxation of airway smooth muscle induced by vasoactive intestinal peptide and electrical field stimulation.

Authors:  S G Farmer; J Togo
Journal:  Br J Pharmacol       Date:  1990-05       Impact factor: 8.739

Review 8.  Decreased neutral endopeptidases: possible role in inflammatory diseases of airways.

Authors:  J A Nadel
Journal:  Lung       Date:  1990       Impact factor: 2.584

9.  Effect of differentiation on the leucine enkephalin-degrading soluble enzymes released by the K562(S) cell line.

Authors:  M Marini; L Bongiorno; A Urbani; E Trani; L G Roda
Journal:  Neurochem Res       Date:  1997-12       Impact factor: 3.996

Review 10.  Mast cell proteases as pharmacological targets.

Authors:  George H Caughey
Journal:  Eur J Pharmacol       Date:  2015-05-07       Impact factor: 4.432

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.